Perghaps I missed it. I was aware that because they changed the contrast for the oral cancer trial the FDA wanted them to gaher more data and resubmit via a different pathway. But this is different, since there seem to additional regulatory changes to meet in addition to the other work that the company has already completed on contrast agents?
Ann: OIL June 2024 Quarterly Report and Appendix 4C, page-5
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $133.6M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 16.5¢ | 16.0¢ | $12.29K | 75.08K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 17061 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 29875 | 2 |
View Market Depth
| Last trade - 15.34pm 10/10/2024 (20 minute delay) ? |
| OIL (ASX) Chart |